Inspiratory Muscle Training in Patients With COVID-19

Covid19 Clinical Trial

Official title:

Efects of Inspiratory Muscle Training in Patients With COVID-19 After Acute Phase. Prospective Study

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT04603963
• Other study ID #: 34931220.1.0000.0071
• Status: Terminated
• Phase: N/A
• Start date: June 1, 2020
• Est. completion date: October 23, 2020

Study information

• Verified date: October 2020
• Source: Hospital Israelita Albert Einstein
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

COVID 19 has become a pandemic and has led to high demand on healthcare systems. It can cause a severe acute respiratory syndrome (SARS CoV-2) which leads to a long hospital stay, developing important functional damage and making hospital discharge difficult. Elderly, obese and people with chronic diseases are more susceptible to contracting the disease, this profile of patients already has a predisposition for respiratory muscle weakness and in this context, after clinical stability, it is still necessary in a hospital environment to approach respiratory and motor physiotherapy. to optimize the recovery of these patients. Objective: Improved breathing, functionality, exercise capacity and muscle strength in non-critical patients. Method: Prospective randomized clinical study where one group received motor and respiratory physiotherapy and the other group performed the same therapy associated with inspiratory muscle training. Results: The findings will be compared before and after the approach and will be presented in graphs and tables. Statistical tests will be used considering a significance level of 5%.

Description:

Prospective clinical study in patients with COVID-19 admitted to a non-critical unit of a tertiary hospital. They were randomized into a group that received motor and respiratory exercises and another group that received the same exercises associated with respiratory muscle training.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 55
• Est. completion date: October 23, 2020
• Est. primary completion date: October 10, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• patients diagnosed with COVID-19 through PCR aged over 18 years admitted to non-critical units.

Exclusion Criteria:

• patients with changes in the level of consciousness and non-transient understanding, exclusive palliative care without prognosis.

Related Conditions & MeSH terms

• Covid19
• Respiration Disorders
• Respiratory Disease
• Respiratory Tract Diseases

Intervention

Device:
• power breathe
respiratory muscle training 1 time a day with power breathe 3 sets of 10 repetitions

Locations

Country	Name	City	State
Brazil	Municipal Hospital Vila Santa Catarina	São Paulo

Sponsors (1)

Lead Sponsor	Collaborator
Elaine Cristina Pereira <elaine.cpereira@einstein.br>

Country where clinical trial is conducted

Brazil, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	impact on functionality	respiratory muscle training appears to impact functionality	14 days